Chapter 6.4. Pulmonary Hypertension

  1. Peter G. Gibson1,
  2. Michael Abramson2,
  3. Richard Wood-Baker3,
  4. Jimmy Volmink4,
  5. Michael Hensley5 and
  6. Ulrich Costabel6
  1. Horst Olschewski

Published Online: 25 OCT 2007

DOI: 10.1002/9780470987377.ch41

Evidence-based Respiratory Medicine

Evidence-based Respiratory Medicine

How to Cite

Olschewski, H. (2005) Pulmonary Hypertension, in Evidence-based Respiratory Medicine (eds P. G. Gibson, M. Abramson, R. Wood-Baker, J. Volmink, M. Hensley and U. Costabel), Blackwell Publishing Ltd, Oxford, UK. doi: 10.1002/9780470987377.ch41

Editor Information

  1. 1

    John Hunter Hospital, Newcastle, New South Wales, Australia

  2. 2

    Monash University, Central & Eastern Clinical School, The Alfred, Melbourne, Victoria, Australia

  3. 3

    University of Tasmania, Hobart, Tasmania, Australia

  4. 4

    University of Cape Town, Cape Town, South Africa

  5. 5

    University of Newcastle, Newcastle, New South Wales, Australia

  6. 6

    Ruhrlandklinik, Essen, Germany

Publication History

  1. Published Online: 25 OCT 2007
  2. Published Print: 22 NOV 2005

ISBN Information

Print ISBN: 9780727916051

Online ISBN: 9780470987377

SEARCH

Keywords:

  • pulmonary hypertension;
  • anticoagulation;
  • respiratory diseases;
  • epoprostenol;
  • beraprost

Summary

This chapter contains sections titled:

  • Classification of pulmonary hypertension

  • Identification of patients with pulmonary hypertension

  • Diagnosis

  • Therapy

  • Therapy of pulmonary venous hypertension

  • Therapy of pulmonary hypertension associated with respiratory diseases

  • Chronic thromboembolic disease

  • Targeted drugs for pulmonary arterial hypertension

  • Therapy decisions for patients with pulmonary arterial hypertension